Effects of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial on Elective Induction and Obstetric Outcomes in Term Nulliparous Patients

Elizabeth Nethery,Barbara Levy,Kate McLean,Kristin Sitcov,Vivienne L. Souter
DOI: https://doi.org/10.1097/ogx.0000000000001247
2024-02-01
Obstetrical & Gynecological Survey
Abstract:(Abstracted from Obstet Gynecol 2023;142:242–250) A few years ago, the ARRIVE trial (A Randomized Trail of Induction Versus Expectant Management) reported that elective induction of labor at 39 weeks of gestation in low-risk nulliparous patients decreased the risk of cesarean birth and of hypertensive disorders of pregnancy compared with expectant management. This presented a possible means to decrease the high rates of cesarean delivery among this patient group.
obstetrics & gynecology
What problem does this paper attempt to address?